Increasing cancer incidence rates in younger and older adults worldwide
1. In this surveillance study, the incidence rates of several cancers increased among both younger and older adults in many ...
Tag: prostate cancer
Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer
1. Progression-free survival and overall survival were significantly greater in the combination therapy group compared to enzalutamide alone. 2. Anemia ...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]
Imfinzi Combo Cuts Gastric Cancer Risk by Twenty Nine Percent Earlier this week at the American Society of Clinical Oncology ...
The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. Jessie ...
Exercise improves sexual function in men with prostate cancer
1. In this randomized clinical trial, exercise was significantly associated with improved sexual function in men with prostate cancer. 2. ...
Genome classifiers may aid prostate cancer risk stratification and treatment
1. In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with wide variation ...
Radiotherapy and abiraterone improve survival in low-volume metastatic castration-sensitive prostate cancer
1. Progression-free survival improved significantly in patients with low-volume disease who received abiraterone and radiotherapy. 2. The addition of radiotherapy ...
Stereotactic body radiotherapy is noninferior to hypofractionated radiotherapy for localized prostate cancer
1. In this randomized controlled trial, among patients with localized prostate cancer, five-fraction stereotactic body radiotherapy (SBRT) was found to ...
#VisualAbstract: Five-Fraction Stereotactic Body Radiotherapy was Noninferior to Control Radiotherapy in Biochemical or Clinical Failure in Localized Prostate Cancer
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
MRI-informed biopsy recommendation reduces overdiagnosis in prostate cancer screening
1. In this randomized controlled trial of men aged 50 to 60, forgoing prostate biopsies in those with elevated PSA ...
